These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Prions, proteinase K and infectivity. Sajnani G; Requena JR Prion; 2012; 6(5):430-2. PubMed ID: 23044510 [TBL] [Abstract][Full Text] [Related]
23. Proteinase K-sensitive disease-associated ovine prion protein revealed by conformation-dependent immunoassay. Thackray AM; Hopkins L; Bujdoso R Biochem J; 2007 Jan; 401(2):475-83. PubMed ID: 17018021 [TBL] [Abstract][Full Text] [Related]
24. Epitope scanning reveals gain and loss of strain specific antibody binding epitopes associated with the conversion of normal cellular prion to scrapie prion. Pan T; Li R; Kang SC; Wong BS; Wisniewski T; Sy MS J Neurochem; 2004 Sep; 90(5):1205-17. PubMed ID: 15312175 [TBL] [Abstract][Full Text] [Related]
25. Annealing prion protein amyloid fibrils at high temperature results in extension of a proteinase K-resistant core. Bocharova OV; Makarava N; Breydo L; Anderson M; Salnikov VV; Baskakov IV J Biol Chem; 2006 Jan; 281(4):2373-9. PubMed ID: 16314415 [TBL] [Abstract][Full Text] [Related]
26. Analyses of protease resistance and aggregation state of abnormal prion protein across the spectrum of human prions. Saverioni D; Notari S; Capellari S; Poggiolini I; Giese A; Kretzschmar HA; Parchi P J Biol Chem; 2013 Sep; 288(39):27972-85. PubMed ID: 23897825 [TBL] [Abstract][Full Text] [Related]
27. Scrapie prion protein structural constraints obtained by limited proteolysis and mass spectrometry. Sajnani G; Pastrana MA; Dynin I; Onisko B; Requena JR J Mol Biol; 2008 Sep; 382(1):88-98. PubMed ID: 18621059 [TBL] [Abstract][Full Text] [Related]
28. Isolation of proteinase K-sensitive prions using pronase E and phosphotungstic acid. D'Castro L; Wenborn A; Gros N; Joiner S; Cronier S; Collinge J; Wadsworth JD PLoS One; 2010 Dec; 5(12):e15679. PubMed ID: 21187933 [TBL] [Abstract][Full Text] [Related]
29. Selective amplification of classical and atypical prions using modified protein misfolding cyclic amplification. Makarava N; Savtchenko R; Baskakov IV J Biol Chem; 2013 Jan; 288(1):33-41. PubMed ID: 23168413 [TBL] [Abstract][Full Text] [Related]
30. Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity. Gasset M; Baldwin MA; Fletterick RJ; Prusiner SB Proc Natl Acad Sci U S A; 1993 Jan; 90(1):1-5. PubMed ID: 8419912 [TBL] [Abstract][Full Text] [Related]
31. Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes. Tzaban S; Friedlander G; Schonberger O; Horonchik L; Yedidia Y; Shaked G; Gabizon R; Taraboulos A Biochemistry; 2002 Oct; 41(42):12868-75. PubMed ID: 12379130 [TBL] [Abstract][Full Text] [Related]
32. Isolation of infectious, non-fibrillar and oligomeric prions from a genetic prion disease. Vanni I; Pirisinu L; Acevedo-Morantes C; Kamali-Jamil R; Rathod V; Di Bari MA; D'Agostino C; Marcon S; Esposito E; Riccardi G; Hornemann S; Senatore A; Aguzzi A; Agrimi U; Wille H; Nonno R Brain; 2020 May; 143(5):1512-1524. PubMed ID: 32303068 [TBL] [Abstract][Full Text] [Related]
33. PK-sensitive PrP is infectious and shares basic structural features with PK-resistant PrP. Sajnani G; Silva CJ; Ramos A; Pastrana MA; Onisko BC; Erickson ML; Antaki EM; Dynin I; Vázquez-Fernández E; Sigurdson CJ; Carter JM; Requena JR PLoS Pathog; 2012; 8(3):e1002547. PubMed ID: 22396643 [TBL] [Abstract][Full Text] [Related]
34. Scrapie infectivity is independent of amyloid staining properties of the N-terminally truncated prion protein. Wille H; Prusiner SB; Cohen FE J Struct Biol; 2000 Jun; 130(2-3):323-38. PubMed ID: 10940236 [TBL] [Abstract][Full Text] [Related]
35. Disruption of prion rods generates 10-nm spherical particles having high alpha-helical content and lacking scrapie infectivity. Riesner D; Kellings K; Post K; Wille H; Serban H; Groth D; Baldwin MA; Prusiner SB J Virol; 1996 Mar; 70(3):1714-22. PubMed ID: 8627692 [TBL] [Abstract][Full Text] [Related]
36. New Molecular Insight into Mechanism of Evolution of Mammalian Synthetic Prions. Makarava N; Savtchenko R; Alexeeva I; Rohwer RG; Baskakov IV Am J Pathol; 2016 Apr; 186(4):1006-14. PubMed ID: 26873446 [TBL] [Abstract][Full Text] [Related]
37. Generation of antisera to purified prions in lipid rafts. Hnasko R; Serban AV; Carlson G; Prusiner SB; Stanker LH Prion; 2010; 4(2):94-104. PubMed ID: 20647769 [TBL] [Abstract][Full Text] [Related]
38. The region approximately between amino acids 81 and 137 of proteinase K-resistant PrPSc is critical for the infectivity of the Chandler prion strain. Shindoh R; Kim CL; Song CH; Hasebe R; Horiuchi M J Virol; 2009 Apr; 83(8):3852-60. PubMed ID: 19176630 [TBL] [Abstract][Full Text] [Related]
39. Reduction of prion infectivity and levels of scrapie prion protein by lithium aluminum hydride: implications for RNA in prion diseases. Jeong BH; Kim NH; Jin JK; Choi JK; Lee YJ; Kim JI; Choi EK; Carp RI; Kim YS J Neuropathol Exp Neurol; 2009 Aug; 68(8):870-9. PubMed ID: 19606066 [TBL] [Abstract][Full Text] [Related]
40. Scrapie infectivity correlates with converting activity, protease resistance, and aggregation of scrapie-associated prion protein in guanidine denaturation studies. Caughey B; Raymond GJ; Kocisko DA; Lansbury PT J Virol; 1997 May; 71(5):4107-10. PubMed ID: 9094691 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]